Bitcoin, Ethereum, Dogecoin Extend Losses Amid Market Gloomby Mark Eisenberg 18.06.2024"Bitcoin, Ethereum, Dogecoin see further losses amid market pessimism. Analysts predict potential recovery despite current declines. Read more now!"
Danone’s Biotech Platform Boosts Precision Fermentationby Mark Eisenberg 18.06.2024Danone, Michelin, and partners launch a €16M Biotech Open Platform to boost precision fermentation for sustainable, bio-based materials.
Western Rare Earth Supply Chain Heats Up with New Developmentsby Mark Eisenberg 18.06.2024"Western companies bolster rare earths supply chain, reduce China's dominance, focus on vital materials for EVs, wind turbines, and drones."
Creators of Ethereum ‘OpenSeason’ Announce Major Token Airdropby John Darbie 18.06.2024Creators of Ethereum NFT game OpenSeason announce free "FU Money" token airdrop for holders of Fractional Uprising Studios NFT membership ...
Enphase EVP Sells $616K in Stock Amid High Valuationby Mark Eisenberg 18.06.2024Enphase Energy EVP sells $600k in stock; Insider transactions may signal personal planning or insights into company’s future. Analyst updates ...
Autodesk’s Blum Sells $3.9M in Shares Amid Market Movementsby Mark Eisenberg 18.06.2024Autodesk COO Steven Blum sells shares worth over $3.9M as part of a trading plan; retains 54,136 shares; Autodesk reports ...
BlockDAG vs DOGE vs ATOM: Price Forecast & Insightsby John Darbie 18.06.2024BlockDAG leads the crypto market revival, surpassing Dogecoin and Cosmos with $51.1M presale; targets $30 valuation by 2030 with advanced ...
Bitcoin Rallies to $67K, XRP Leads Altcoin Surgeby John Darbie 18.06.2024Bitcoin bounces back to $67K after volatile week; XRP leads altcoin recovery with 5% gain. Bitcoin miners and traditional markets ...
7 Breakthrough Biotech Stocks to Boost Your Portfolio in 2023by Lilu Anderson 18.06.2024"Discover 7 breakthrough biotech stocks poised to boost your portfolio in a sector projected to reach $521.6B by 2033. Learn ...
Aerovate Therapeutics Stock Downgraded After Trial Setbackby Mark Eisenberg 17.06.2024Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.